Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants

Fig. 4

The supernumerary prognostic factors for death of cancer patients with COVID-19. A Age (old vs. young); B Gender (male vs. female); C Hypertension (yes vs. no); D Diabetes (yes vs. no); E Chronic obstructive pulmonary disease (COPD) (yes vs. no); F Cardiovascular disease (yes vs. no); G Smoking (yes vs. no); H Eastern Cooperative Oncology Group Performance Scale (ECOG PS) (high vs. low); I Type of solid tumor (lung cancer vs. other solid tumor); J White blood cell count (high vs. normal); K C-reactive protein (high vs. normal)

Back to article page